De Lisle Partners LLP Grows Stake in UFP Technologies, Inc. (NASDAQ:UFPT)

De Lisle Partners LLP increased its position in UFP Technologies, Inc. (NASDAQ:UFPT) by 30.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 66,573 shares of the industrial products company’s stock after buying an additional 15,603 shares during the period. UFP Technologies accounts for approximately 3.4% of De Lisle Partners LLP’s investment portfolio, making the stock its 3rd biggest holding. De Lisle Partners LLP owned about 0.87% of UFP Technologies worth $21,070,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Congress Asset Management Co. raised its holdings in UFP Technologies by 0.4% during the third quarter. Congress Asset Management Co. now owns 246,303 shares of the industrial products company’s stock worth $78,004,000 after buying an additional 986 shares during the last quarter. Massachusetts Financial Services Co. MA increased its position in shares of UFP Technologies by 2.6% during the second quarter. Massachusetts Financial Services Co. MA now owns 105,118 shares of the industrial products company’s stock worth $27,737,000 after acquiring an additional 2,699 shares in the last quarter. Swedbank AB acquired a new stake in shares of UFP Technologies in the 1st quarter worth about $25,220,000. Mountain Pacific Investment Advisers LLC lifted its position in UFP Technologies by 0.3% in the 3rd quarter. Mountain Pacific Investment Advisers LLC now owns 92,976 shares of the industrial products company’s stock valued at $29,445,000 after acquiring an additional 238 shares in the last quarter. Finally, Geneva Capital Management LLC boosted its stake in UFP Technologies by 0.3% during the 3rd quarter. Geneva Capital Management LLC now owns 80,362 shares of the industrial products company’s stock valued at $25,450,000 after purchasing an additional 243 shares during the last quarter. 87.28% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, Director Cynthia L. Feldmann sold 647 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $352.30, for a total transaction of $227,938.10. Following the transaction, the director now directly owns 4,049 shares in the company, valued at approximately $1,426,462.70. The trade was a 13.78 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Jason Holt sold 146 shares of the company’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $342.69, for a total transaction of $50,032.74. Following the completion of the sale, the vice president now directly owns 6,721 shares of the company’s stock, valued at $2,303,219.49. The trade was a 2.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 13,326 shares of company stock worth $4,620,154. 6.17% of the stock is owned by corporate insiders.

UFP Technologies Stock Performance

Shares of UFPT opened at $321.92 on Thursday. UFP Technologies, Inc. has a 52 week low of $152.43 and a 52 week high of $366.41. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.43 and a current ratio of 2.57. The stock has a 50 day moving average price of $307.63 and a two-hundred day moving average price of $298.77. The firm has a market capitalization of $2.47 billion, a P/E ratio of 45.92 and a beta of 0.96.

About UFP Technologies

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.